Actively Recruiting
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
Led by Institut Paoli-Calmettes · Updated on 2020-07-01
5000
Participants Needed
1
Research Sites
1513 weeks
Total Duration
On this page
Sponsors
I
Institut Paoli-Calmettes
Lead Sponsor
U
UNICANCER - Le Groupe génétique et cancer (GGC)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers
CONDITIONS
Official Title
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Woman or man aged 18 years or older carrying a harmful BRCA1 or BRCA2 gene mutation
- Women with or without breast or ovarian cancer at the start of the study
- Men with or without breast cancer at the start of the study
- Signed consent to participate in the study
- Affiliated with or beneficiary of a social security system
You will not qualify if you...
- Individuals under legal protection or unable to provide consent
- Unable to participate in follow-up due to geographical, social, or psychological reasons
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut Paoli-Calmettes
Marseille, France, 13009
Actively Recruiting
Research Team
D
Dominique GENRE, MD
CONTACT
M
Margot BERLINE, MSc, MBA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here